Phase 3 study results show high efficacy and improved renal and bone safety parameters with tenofovir alafenamide regimen.
Lauren Santye, Assistant Editor
Advertisement
Articles by Lauren Santye, Assistant Editor
Researchers achieve promising first step in new HIV treatment approach.
Sofosbuvir and velpastavir combination being evaluated for hepatitis C genotypes 1-6.
Palbociclib has been found effective inhibiting the mobilization of enzymes that contribute to the rapid division of tumor cells.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5
